Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the impact of the last recommendations of the European Anemia Working Group ERBP in the anemia management in the achievement of the therapeutic goal of Hb 11-12 g/dL.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| % Patients Achieving Target Hemoglobin Levels | % patients with Hb levels between 11-12 mg/dl | 1 day because is a crosssectional study with only a visit |
| Measure | Description | Time Frame |
|---|---|---|
| Hemoglobin Levels Per Type of Patients | levels Hb and type of patients | 1 day |
| Patients With Hb>12 | 1 day | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adults patients with anemia secondary to chronic kidney disease (CKD) not on dyalisis.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Alberto Martinez Castelao, Doctor | Hospital Bellvitge | Principal Investigator |
| Aleix Cases, Doctor | Hospital Clinic of Barcelona | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Puerto Real | Cadiz | Andalusia | Spain | |||
| Hospital de Jerez |
14 patients were excluded because they didn't fulfill the eligibility criteria
Nephrology Units of 30 Spanish hospitals.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Patients With Anemia and CKD | Adults patients with anemia secondary to chronic kidney disease (CKD) not on dialysis. |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| % Patients With Erythropoiesis Stimulating Agents (ESA) Therapy |
know the treatments ESA for maintenance of hb levels |
| 1 day |
| Iron Treatment | Patients with supplementary Iron treatment to ESA | 1 day |
| Patients With Hb<11 | 1 day |
| Jerez de la Frontera |
| Andalusia |
| Spain |
| Clínico V. Victoria | Málaga | Andalusia | Spain |
| Hospital Son Llatzer | Palma de Mallorca | Balearic Islands | Spain |
| Hospital Universitario Nuestra Señora De Candelaria | Santa Cruz de Tenerife | Canary Islands | Spain |
| Hospital Marques de Valdecilla | Santander | Cantabria | Spain |
| Hospital Virgen de la Luz | Toledo | Castille-La Mancha | Spain |
| Fundación Puigvert | Barcelona | Catalonia | Spain |
| Hospital Bellvige | Barcelona | Catalonia | Spain |
| Hospital Bellvitge | Barcelona | Catalonia | Spain |
| Hospital Clinic | Barcelona | Catalonia | Spain |
| Hospital Germans Trias i Pujol | Barcelona | Catalonia | Spain |
| Hospital Valld'Hebron | Barcelona | Catalonia | Spain |
| Sagrat Cor | Barcelona | Catalonia | Spain |
| Clinica Girona | Girona | Catalonia | Spain |
| Hospital Josep Trueta | Girona | Catalonia | Spain |
| Arquitecto Marcide | Ferrol | Galicia | Spain |
| Complexo Hospitalario de Ourense | Ourense | Galicia | Spain |
| Complejo Hospitalario Universitario de Santiago | Santiago de Compostela | Galicia | Spain |
| Hospital 12 de Octubre | Madrid | Madrid | Spain |
| Hospital Clínico San Carlos | Madrid | Madrid | Spain |
| Hospital Gregorio Marañón | Madrid | Madrid | Spain |
| Hospital La Paz | Madrid | Madrid | Spain |
| Hospital La Princesa | Madrid | Madrid | Spain |
| Hospital General de Alicante | Alicante | Valencia | Spain |
| Hospital de Castellón | Castellon | Valencia | Spain |
| Hospital Clínico de Valencia | Valencia | Valencia | Spain |
| Hospital Dr. Peset | Valencia | Valencia | Spain |
| Hospital La Fe | Valencia | Valencia | Spain |
| COMPLETED |
|
| NOT COMPLETED |
|
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Converted Patients | Patients in treatment who changed from previous ESA treatment since January 2011 |
| BG001 | Naïve Patients | Patients starting anemia treatment (naïve) after six months of the last recommendations of the Anemia Working Group of ERBP (January 2011) |
| BG002 | Total | Total of all reporting groups |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age Continuous | Mean | Standard Deviation | years |
| |||||||||||||||
| Sex: Female, Male | Count of Participants | Participants |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | % Patients Achieving Target Hemoglobin Levels | % patients with Hb levels between 11-12 mg/dl | Posted | Number | percentage of participants | 1 day because is a crosssectional study with only a visit |
|
|
| ||||||||||||||||||||||||||||||
| Secondary | Hemoglobin Levels Per Type of Patients | levels Hb and type of patients | n represents the number of participants analyzed for each category respectively (converted patients, naïve patients) | Posted | Mean | Standard Deviation | mg/dl | 1 day |
|
| |||||||||||||||||||||||||||||
| Secondary | Patients With Hb>12 | Posted | Number | participants | 1 day |
|
| ||||||||||||||||||||||||||||||||
| Secondary | % Patients With Erythropoiesis Stimulating Agents (ESA) Therapy | know the treatments ESA for maintenance of hb levels | Posted | Number | percentage of participants | 1 day |
|
| |||||||||||||||||||||||||||||||
| Secondary | Iron Treatment | Patients with supplementary Iron treatment to ESA | Posted | Number | participants | 1 day |
|
| |||||||||||||||||||||||||||||||
| Secondary | Patients With Hb<11 | Posted | Number | participants | 1 day |
|
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Converted Patients | Patients in treatment who changed from previous ESA treatment since January 2011 | 1 | 143 | 3 | 143 | ||
| EG001 | Naïve Patients | Patients starting anemia treatment (naïve) after six months of the last recommendations of the Anemia Working Group of ERBP (January 2011) | 1 | 298 | 1 | 298 |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Hipercalcemia | Vascular disorders | Systematic Assessment |
| ||
| Cardiac insufficiency left side | Cardiac disorders | Systematic Assessment |
|
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Precordial pain | Cardiac disorders | Non-systematic Assessment |
| ||
| auricular fibrilation | Cardiac disorders | Non-systematic Assessment |
| ||
| Urinary infection | Renal and urinary disorders | Non-systematic Assessment |
| ||
| orquiepididimitis | Renal and urinary disorders | Non-systematic Assessment |
| ||
| Change sounds nefrostomia | Renal and urinary disorders | Systematic Assessment |
|
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Alberto Martínez Castelao | Hospital de Bellvitge | 610 459 262 | albertomcastelao@gmail.com |
| ID | Term |
|---|---|
| D000740 | Anemia |
| ID | Term |
|---|---|
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
Not provided
Not provided
| Male |
|
|
|
|
|
|